German Health Minister Jens Spahn and German State Minister for Migration, Refugees and Integration Annette Widmann-Mauz arrive to the weekly cabinet meeting at the Chancellery following the outbreak of the coronavirus disease (COVID-19) in Berlin, Germany, May 27, 2020. Tobias Schwarz/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen leaves a House Energy and Commerce Subcommittee on Health hearing, held to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill, in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Chairman Rep. Anna Eshoo (D-CA) responds to a question after attending a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Chairman Rep. Anna Eshoo (D-CA) responds to a question after attending a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Chairman Rep. Anna Eshoo (D-CA) responds to a question after attending a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Chairman Rep. Anna Eshoo (D-CA) arrives to addresses the media after attending a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Chairman Rep. Anna Eshoo (D-CA) addresses the media after attending a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Chairman Rep. Anna Eshoo (D-CA) arrives to addresses the media after attending a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Chairman Rep. Anna Eshoo (D-CA) addresses the media after attending a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Rep. Buddy Carter (R-GA) asks questions to Mike Bowen, Executive Vice President of Prestige Ameritech, during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Rep. Buddy Carter (R-GA) asks questions to Mike Bowen, Executive Vice President of Prestige Ameritech, during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Rep. Tony Cardenas (D-CA) cleans his belongings during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Rep. Larry Bucshon (R-IN) speaks to Reps. Susan Brooks (R-IN) and Markwayne Mullin (R-OK) during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Executive Vice President of Prestige Ameritech Mike Bowen testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, passes by Mike Bowen, Executive Vice President of Prestige Ameritech, as he leaves a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, leaves a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, leaves a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Chairman Rep. Anna Eshoo (D-CA) attends a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Rep. Tony Cardenas (D-CA) leaves a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Rep. Billy Long (R-MO) asks questions to Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Rep. Richard Hudson (R-NC) asks questions to Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Rep. Raul Ruiz (D-CA) wipes down his microphone during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Rep. Nanette Barragan (D-CA) asks questions to Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Rep. Debbie Dingell (D-MI) asks questions to Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Rep. Joe Kennedy III (D-MA) asks questions to Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Rep. Ann Kuster (D-NH) asks questions to Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Rep. Peter Welch (D-VT) asks questions to Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Shawn Thew/Pool via REUTERS

Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, testifies during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS

Democratic members are seen during a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus disease (COVID-19) outbreak on Capitol Hill in Washington, U.S., May 14, 2020. Greg Nash/Pool via REUTERS